May 6 |
Telesis Bio Announces Reverse Stock Split
|
Apr 18 |
Telesis Bio announces leadership transition amid new commercial focus
|
Apr 18 |
Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership
|
Mar 28 |
Telesis Bio GAAP EPS of -$0.61, revenue of $7M
|
Mar 28 |
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
|
Feb 27 |
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
|
Feb 26 |
Telesis Bio announces 26.3% drop in prelim Q4 revenue
|
Feb 26 |
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
|